Ronald E. Pauli
Director of Finance/CFO at BioQ Pharma, Inc.
Ronald E. Pauli active positions
Companies | Position | Start | End |
---|---|---|---|
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | Director of Finance/CFO | - | - |
Career history of Ronald E. Pauli
Former positions of Ronald E. Pauli
Companies | Position | Start | End |
---|---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Director/Board Member | 18/09/2014 | 01/05/2019 |
Independent Dir/Board Member | 18/09/2014 | 01/05/2019 | |
SAGENT PHARMACEUTICALS INC | Director of Finance/CFO | 31/03/2007 | 25/08/2011 |
Investor Relations Contact | 11/05/2011 | 22/05/2012 | |
Public Communications Contact | 24/08/2011 | 22/05/2012 | |
Corporate Officer/Principal | 25/08/2011 | 28/08/2011 | |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | Director of Finance/CFO | 19/04/2011 | 19/04/2011 |
Investor Relations Contact | 19/04/2011 | 19/04/2011 | |
Public Communications Contact | 31/03/2007 | 19/04/2011 | |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Director of Finance/CFO | 20/03/2007 | 20/03/2007 |
Corporate Secretary | 20/03/2007 | 20/03/2007 | |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Comptroller/Controller/Auditor | 31/12/2001 | 31/12/2005 |
Director of Finance/CFO | 31/12/2001 | 31/12/2005 | |
Horizon Pharma, Inc.
Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL. | Director/Board Member | 02/10/2011 | 18/09/2014 |
Independent Dir/Board Member | 28/09/2011 | 18/09/2014 | |
Applied Power Corp
Applied Power Corp Electric UtilitiesUtilities Part of Carl-Zeiss-Stiftung, Applied Power Corp is a company that supplies electricity. The company is based in Boise, ID. Applied Power was acquired by Schott Corp. from IDACORP, Inc. on January 17, 2001. | Comptroller/Controller/Auditor | - | - |
CATALENT PHARMA SOLUTIONS, INC. | Comptroller/Controller/Auditor | - | - |
░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - | |
░░░░░░░ ░░░░ ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
Training of Ronald E. Pauli
Michigan State University | Undergraduate Degree |
Walsh College | Graduate Degree |
Statistics
International
United States | 14 |
Ireland | 2 |
Canada | 2 |
Operational
Comptroller/Controller/Auditor | 6 |
Director of Finance/CFO | 6 |
Corporate Officer/Principal | 3 |
Sectoral
Health Technology | 9 |
Consumer Services | 3 |
Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ENERPAC TOOL GROUP CORP. | Producer Manufacturing |
Private companies | 12 |
---|---|
R.P. Scherer Corp.
R.P. Scherer Corp. Pharmaceuticals: MajorHealth Technology R.P. Scherer Corp. Develops and manufactures oral drug delivery systems. The company offers different types of medical services and products. It has approximately 4 medical faculties in United States. The company is located in Troy, MI | Health Technology |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Health Technology |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Ersco Corp
Ersco Corp Wholesale DistributorsDistribution Services Part of Maxco, Inc., Ersco Corp provides a full line of concrete construction supplies. The company is based in Okemos, MI. | Distribution Services |
Applied Power Corp
Applied Power Corp Electric UtilitiesUtilities Part of Carl-Zeiss-Stiftung, Applied Power Corp is a company that supplies electricity. The company is based in Boise, ID. Applied Power was acquired by Schott Corp. from IDACORP, Inc. on January 17, 2001. | Utilities |
Kmart Corp.
Kmart Corp. Discount StoresRetail Trade Kmart Corp. engages in retailing of general merchandise. It also offers pharmacy services. The company was founded by Sebastian S. Kresge in 1899 and is headquartered in Hoffman Estates, IL. | Retail Trade |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
Ernst & Whinney | Commercial Services |
Horizon Pharma, Inc.
Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL. | Health Technology |
- Stock Market
- Insiders
- Ronald E. Pauli
- Experience